Evidence map›Paper›PMID 33230531›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2021

NECAB1 and NECAB2 are Prevalent Calcium-Binding Proteins of CB1/CCK-Positive GABAergic Interneurons.

Vivien Miczán, Krisztina Kelemen, Judit R Glavinics, Zsófia I László, Benjámin Barti, Kata Kenesei, Máté Kisfali, István Katona

Open access · hybridAbstract read
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Genetic pleiotropy differentially linking brain variation to cannabis use and cannabis use disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Vivien MiczánMomentum Laboratory of Molecular Neurobiology, Institute of Experimental Medicine, Budapest 1083, Hungary.
Krisztina KelemenMomentum Laboratory of Molecular Neurobiology, Institute of Experimental Medicine, Budapest 1083, Hungary.
Judit R GlavinicsMomentum Laboratory of Molecular Neurobiology, Institute of Experimental Medicine, Budapest 1083, Hungary.
Zsófia I LászlóMomentum Laboratory of Molecular Neurobiology, Institute of Experimental Medicine, Budapest 1083, Hungary.
Benjámin BartiMomentum Laboratory of Molecular Neurobiology, Institute of Experimental Medicine, Budapest 1083, Hungary.
Kata KeneseiMomentum Laboratory of Molecular Neurobiology, Institute of Experimental Medicine, Budapest 1083, Hungary.
Máté KisfaliMomentum Laboratory of Molecular Neurobiology, Institute of Experimental Medicine, Budapest 1083, Hungary.
István KatonaMomentum Laboratory of Molecular Neurobiology, Institute of Experimental Medicine, Budapest 1083, Hungary.
HUN-REN Institute of Experimental Medicine · HUSemmelweis University · HUPázmány Péter Catholic University · HUUniversitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș · RO

Funding

Cannabinoid control of epilepsyR01NS099457 · NINDS · STANFORD UNIVERSITY · PI SOLTESZ, IVAN · 2017 to 2021
$1.8M
Neurodevelopmental Effects of THC on The VTA Dopamine System and BehaviorR01DA044925 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI CHEER, JOSEPH F · 2018 to 2022
$1.7M
NIDA NIH HHS R01 DA044925NINDS NIH HHS R01 NS099457
6 · The paper itself

Abstract

The molecular repertoire of the "Ca2+-signaling toolkit" supports the specific kinetic requirements of Ca2+-dependent processes in different neuronal types. A well-known example is the unique expression pattern of calcium-binding proteins, such as parvalbumin, calbindin, and calretinin. These cytosolic Ca2+-buffers control presynaptic and somatodendritic processes in a cell-type-specific manner and have been used as neurochemical markers of GABAergic interneuron types for decades. Surprisingly, to date no typifying calcium-binding proteins have been found in CB1 cannabinoid receptor/cholecystokinin (CB1/CCK)-positive interneurons that represent a large population of GABAergic cells in cortical circuits. Because CB1/CCK-positive interneurons display disparate presynaptic and somatodendritic Ca2+-transients compared with other interneurons, we tested the hypothesis that they express alternative calcium-binding proteins. By in silico data mining in mouse single-cell RNA-seq databases, we identified high expression of Necab1 and Necab2 genes encoding N-terminal EF-hand calcium-binding proteins 1 and 2, respectively, in CB1/CCK-positive interneurons. Fluorescent in situ hybridization and immunostaining revealed cell-type-specific distribution of NECAB1 and NECAB2 throughout the isocortex, hippocampal formation, and basolateral amygdala complex. Combination of patch-clamp electrophysiology, confocal, and STORM super-resolution microscopy uncovered subcellular nanoscale differences indicating functional division of labor between the two calcium-binding proteins. These findings highlight NECAB1 and NECAB2 as predominant calcium-binding proteins in CB1/CCK-positive interneurons.

Indexed as

AnimalsBrainCalcium-Binding ProteinsCholecystokininEye ProteinsGABAergic NeuronsInterneuronsMaleMiceMice, Inbred C57BLReceptor, Cannabinoid, CB1Calcium-Binding ProteinsCholecystokininEye ProteinsNECAB2 protein, mouseNecab3 protein, mouseReceptor, Cannabinoid, CB1basolateral amygdalaCa2+-bufferingcerebral cortexhippocampusinhibitory cell

Identifiers

PMID33230531
PMCPMC7869086
OpenAlexW3108370262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.